Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets |
| BNF code | 0503060B0AAAAAA |
| Basis of preferred name | Other |
| Date of name applicability | 16 Mar 2022 |
| Previous name | PF-07321332 150mg tablets and Ritonavir 100mg tablets |
| Basis of previous name | Other |
| Reason for name change | New approved generic name available |
| Combination product | Combination Product |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Not applicable |
| Dose Form | |
|---|---|
| Formulation | Not applicable |
| Drug Route | |
| Route | Route of administration not applicable |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Paxlovid 150mg/100mg tablets (Pfizer Ltd) | |
| Virtual Medicinal Product Packs | |
| Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets 30 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.